<DOC>
	<DOCNO>NCT01154218</DOCNO>
	<brief_summary>The purpose study demonstrate bioequivalence Commercial Image Capsule ( CIC ) relative Immediate Release Tablet ( IRT ) crizotinib , bioequivalence CIC relative Powder Capsule ( PIC ) crizotinib , lack effect high fat meal pharmacokinetics ( PK ) crizotinib administer CIC Formulation healthy volunteer .</brief_summary>
	<brief_title>Bioequivalence And Food Effect Study Comparing The Commercial Formulation Of Crizotinib To Its Clinical Study Formulations And Commercial Formulation With Or Without Food In Healthy Volunteers</brief_title>
	<detailed_description>The purpose study demonstrate bioequivalence CIC relative IRT CIC relative PIC , lack effect food PK crizotinib healthy volunteer .</detailed_description>
	<mesh_term>Crizotinib</mesh_term>
	<criteria>Healthy male and/or female nonchildbearing potential subject age 18 55 year , inclusive ( Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12lead ECG clinical laboratory test ) . Body Mass Index ( BMI ) 17.5 30.5 kg/m^2 ; total body weight &gt; 50 kg ( 110 lb ) Subjects smoking , evidence disease , condition affect absorption , treatment investigational drug within 30 day , history regular alcohol consumption , use prescription , nonprescription drug dietary supplement within 7 day , blood donation 500 mL within 56 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>bioequivalence</keyword>
	<keyword>food effect</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>crizotinib</keyword>
</DOC>